Adverse effect of Avastin treatment
- Share via
Times Wire Reports
Genentech Inc. has received 36 reports of eye inflammation in Canadian patients who were given the cancer drug Avastin to treat eye diseases.
The South San Francisco company said the injuries developed when doctors used Avastin to treat macular degeneration or diabetic retinopathy. Avastin isn’t approved for use in the chronic eye diseases.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
